Connection
Eric Simoes to Respiratory Syncytial Virus, Human
This is a "connection" page, showing publications Eric Simoes has written about Respiratory Syncytial Virus, Human.
|
|
Connection Strength |
|
 |
|
 |
|
1.303 |
|
|
|
-
Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20.
Score: 0.195
-
Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S21-32.
Score: 0.195
-
Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002 Apr; 96 Suppl B:S1-7.
Score: 0.184
-
Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis--the story so far. Respir Med. 2002 Apr; 96 Suppl B:S15-24.
Score: 0.184
-
Ponnuraj EM, Hayward AR, Raj A, Wilson H, Simoes EAF. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J Gen Virol. 2001 Nov; 82(Pt 11):2663-2674.
Score: 0.178
-
Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics). Pediatr Ann. 1999 Aug; 28(8):507-14.
Score: 0.153
-
Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:39-57.
Score: 0.097
-
Madhi SA, Cutland CL, Downs S, Jones S, van Niekerk N, Simoes EAF, Nunes MC. Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study. Clin Infect Dis. 2018 05 17; 66(11):1658-1665.
Score: 0.035
-
Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M, Kramer A, Hemming V. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 1997 Dec; 100(6):937-42.
Score: 0.034
-
Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin. Antimicrob Agents Chemother. 1995 Mar; 39(3):668-71.
Score: 0.028
-
Weinberg A, Brewster L, Clark J, Simoes E. Evaluation of R-Mix shell vials for the diagnosis of viral respiratory tract infections. J Clin Virol. 2004 May; 30(1):100-5.
Score: 0.013
-
Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|